Dr. Silvia Priori to lead Cardiovascular Genetics Program

Dr. Silvia G. Priori leads Cardiovascular Genetics Program. 

Dr. Priori is internationally recognized for her studies identifying the genetic basis and optimum therapy for patients at risk of inherited forms of cardiac arrhythmias.  As Director of Molecular Cardiology and Electrophysiology Laboratories at Fondazione Salvatore Maugeri in Pavia, Italy, Dr. Priori established the world’s largest referral center for patients with inherited cardiac ion channel disorders.  Her group developed genetic testing for many of these diseases.  In addition, Dr. Priori’s research team has pursued the molecular pathophysiology of these disorders through the creation of mouse modeling as well as molecular, cellular and biophysical studies of the mutant ion channels.

Dr. Priori is working closely with our cardiac electrophysiology team, directed by Dr. Larry Chinitz, to establish a clinical program designed to evaluate patients and families potentially at risk for life-threatening inherited heart rhythm disorders, including Long QT syndrome (LQTS), Brugada syndrome, Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), and related disorders.  The program facilitates genetic testing and assists in patient management.

As part of the new program, a joint clinical database has been established, linking patients evaluated at NYU as well as those seen in Pavia, Italy.  Dr. Priori will also establish a translational research program in the Joan and Joel Smilow Research Center, which will focus on furthering our understanding of the the molecular basis for inherited arrhythmias and also explore novel therapies for patients at risk of sudden cardiac death.

Patients will be seen in the Heart Rhythm Center in the Rivergate Building, 403 East 34th Street. 

For appointments, call 212-263-7149.

 

Resources